| Improved tumor control through T-cell infiltration modulated by ultra-high dose rate proton FLASH using a clinical pencil beam scanning proton system N Rama, T Saha, S Shukla, C Goda, D Milewski, AE Mascia, RE Vatner, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), S164-S165, 2019 | 80 | 2019 |
| FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch in myofibroblasts M Black, D Milewski, T Le, X Ren, Y Xu, VV Kalinichenko, TV Kalin Cell reports 23 (2), 442-458, 2018 | 78 | 2018 |
| Targeted inhibition of the dual specificity phosphatases DUSP1 and DUSP6 suppress MPNST growth via JNK A Ramkissoon, KE Chaney, D Milewski, KB Williams, RL Williams, K Choi, ... Clinical Cancer Research 25 (13), 4117-4127, 2019 | 67 | 2019 |
| FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor D Milewski, A Pradhan, X Wang, Y Cai, T Le, B Turpin, VV Kalinichenko, ... Oncogene 36 (6), 850-862, 2017 | 60 | 2017 |
| FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas D Milewski, D Balli, V Ustiyan, T Le, H Dienemann, A Warth, K Breuhahn, ... PLoS genetics 13 (12), e1007097, 2017 | 59 | 2017 |
| Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway C Goda, D Balli, M Black, D Milewski, T Le, V Ustiyan, X Ren, ... PLoS Genetics 16 (4), e1008692, 2020 | 45 | 2020 |
| The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5 L Fulford, D Milewski, V Ustiyan, N Ravishankar, Y Cai, T Le, S Masineni, ... Science Signaling 9 (427), ra48-ra48, 2016 | 44 | 2016 |
| The FOXM1 inhibitor RCM-1 decreases carcinogenesis and nuclear β-catenin S Shukla, D Milewski, A Pradhan, N Rama, K Rice, T Le, MJ Flick, S Vaz, ... Molecular cancer therapeutics 18 (7), 1217-1229, 2019 | 39 | 2019 |
| Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma S Pomella, P Sreenivas, BE Gryder, L Wang, D Milewski, M Cassandri, ... Nature communications 12 (1), 192, 2021 | 38 | 2021 |
| An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma M Tian, AT Cheuk, JS Wei, A Abdelmaksoud, HC Chou, D Milewski, ... The Journal of Clinical Investigation 132 (16), 2022 | 36 | 2022 |
| Immuno-transcriptomic profiling of extracranial pediatric solid malignancies AS Brohl, S Sindiri, JS Wei, D Milewski, HC Chou, YK Song, X Wen, ... Cell reports 37 (8), 2021 | 36 | 2021 |
| FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation M Black, P Arumugam, S Shukla, A Pradhan, V Ustiyan, D Milewski, ... Molecular Biology of the Cell 31 (13), 1411-1424, 2020 | 28 | 2020 |
| FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma D Milewski, S Shukla, BE Gryder, A Pradhan, J Donovan, P Sudha, ... Oncogene 40 (12), 2182-2199, 2021 | 20 | 2021 |
| Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling F Bian, YW Lan, S Zhao, Z Deng, S Shukla, A Acharya, J Donovan, T Le, ... Nature Communications 14 (1), 2560, 2023 | 17 | 2023 |
| Proteogenomic analysis unveils the HLA class I-presented immunopeptidome in melanoma and EGFR-mutant lung adenocarcinoma YA Qi, TK Maity, CM Cultraro, V Misra, X Zhang, C Ade, S Gao, D Milewski, ... Molecular & Cellular Proteomics 20, 2021 | 17 | 2021 |
| Targeting Eya3 in Ewing Sarcoma Retards tumor growth and angiogenesis Y Wang, RN Pandey, K Roychoudhury, D Milewski, TV Kalin, S Szabo, ... Molecular cancer therapeutics 20 (5), 803-815, 2021 | 10 | 2021 |
| A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia KE Masih, RA Gardner, HC Chou, A Abdelmaksoud, YK Song, L Mariani, ... Blood Advances 7 (15), 4218-4232, 2023 | 8 | 2023 |
| IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models A Gasilina, G Premnauth, P Gurjar, J Biesiada, S Hegde, D Milewski, ... PloS one 15 (3), e0229801, 2020 | 8 | 2020 |
| Exploring and targeting the tumor immune microenvironment of neuroblastoma KE Masih, JS Wei, D Milewski, J Khan Journal of cellular immunology 3 (5), 305, 2021 | 4 | 2021 |
| Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma M Tian, JS Wei, N Shivaprasad, SL Highfill, BE Gryder, D Milewski, ... Cell Reports Medicine 4 (10), 2023 | 3 | 2023 |
